Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SR 144528-d3 is intended for use as an internal standard for the quantification of SR 144528 (Item No. 9000491) by GC- or LC-MS. SR 144528 is a cannabinoid 2 (CB2) receptor antagonist (Ki = 0.6 nM).1 It is selective for CB2 over CB1 receptors in CHO cells expressing the human receptors (Ki = 437 nM).2 SR 144528 reverses CP 55,940-induced inhibition of forskolin-induced adenylyl cyclase activity in CHO cells expressing human CB2 receptors (EC50 = 10 nM). SR 144528 (0.01 mg/kg) reduces paw swelling in a mouse model of carrageenan-induced paw edema.3
WARNING This product is not for human or veterinary use.
1. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6(8), 635-664 (1999).
2. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284(2), 644-650 (1998).
3. In vitro and in vivo pharmacological characterization of JTE-